-+ 0.00%
-+ 0.00%
-+ 0.00%

MOONLAKE IMMUNOTHERAPEUTICS SHARES RISE 35% PREMARKET AFTER MEETING WITH US FDA REGARDING CO'S SKIN DISEASE DRUG MARKETING APPLICATION

Reuters·01/08/2026 13:22:57

Please log in to view news